Skip to content

Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery

· 0 citations · 45 references

TL;DR

This study redesigned the AZ67 allosteric scaffold to prioritise computational leads for anticancer metabolic drug discovery and selected the least variable ligand trajectory among the derivatives and an MM/GBSA profile near -65 kcal/mol versus approximately -40 kcal/mol for AZ67.

View source

Similar papers

Open access Aug 2026

De Novo Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery

PFKFB3 is a druggable regulator of fructose-2,6-bisphosphate production, glycolytic flux, angiogenic metabolism, and tumour-cell survival signalling. This study redesigned the AZ67 allosteric scaffold to prioritise computational leads for anticancer metabolic drug discovery. ChemoDOTS enumeration produced 575,760 virtu...

A. Mohammed, Jameelah K. T. Al-Isawi, M. K. Abd · 0 citations
Oct 2026

Structure-based drug repurposing for CDK6: Molecular docking and molecular dynamics characterization of FDA-approved non-oncological compounds.

Cyclin-dependent kinase 6 (CDK6) contributes to G1-to-S cell-cycle progression and represents an established therapeutic target in hormone receptor-positive breast cancer. However, adverse effects and acquired resistance associated with current CDK4/6 inhibitors support continued investigation of alternative chemical s...

Syarifuddin Husain, Ruzianisra Mohamed, Khairul Bariyyah Abd. Halim et al. · 0 citations
Review Open access Aug 2026

Integrated molecular docking, toxicity prediction, and molecular dynamics simulations studies to identify potential antimalarial candidates targeting enoyl-acyl carrier protein reductase enzyme

A cost-effective computational workflow for prioritizing ENR inhibitors is demonstrated, providing a foundation for the development of novel antimalarial agents and highlighting Cd3 and Cd5 as the most promising candidates for further development.

Abozur Mohamed Mohyeldin Khalil, Carlos Eliel Maya-Ramírez, A. A. Razzak Mahmood et al. · 0 citations
Open access Aug 2026

In Silico Optimization of Dihydropteridine Derivatives Targeting PLK1 for Glioblastoma: An Integrated QSAR, Docking, and Molecular Dynamics Study

Computational findings support the prioritization of X14 for further experimental validation in glioblastoma therapy, and generally favorable ADMET profiles were observed, hepatotoxicity alerts were predicted for all compounds, which represents an important limitation supporting the prioritization of X14.

Youssef Briach, M. Er-rajy, Jamal Elkhabchi et al. · 0 citations
Open access Aug 2026

Integrated Computational Study Prioritizes Drug-like Para-Flavonoids as Candidate SARS-CoV-2 Mpro Inhibitors

Seven para-substituted flavonoid hybrids against the main protease (Mpro) are designed and M6 is prioritized as a computational lead requiring Mpro inhibition, antiviral, and cytotoxicity validation.

Jawaher H. Alqahtani, Mohammed Ouachekradi, Bahia Abdelfattah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.